NEW YORK (GenomeWeb News) – When the US Senate last week passed an amendment to the war funding bill that earmarked an additional $400 million for the National Institutes of Health’s 2008 budget, it also ushered along funding for two other agencies that have been seeking bigger budgets: the US Food and Drug Administration and the US Centers for Disease Control and Prevention.
The supplemental appropriations bill would add $26 million to the CDC’s budget, of which at least $5 million must go to responses to outbreaks of communicable diseases, including genetic sequencing of those who potentially have been exposed to such diseases.
The CDC’s budget for 2008 is around $6.1 billion, and President Bush has requested $5.7 billion for 2009.
The supplemental appropriations bill also would commit $48.5 million to the FDA’s Center for Drug Evaluation and Research and related field activities in the Office of Regulatory Affairs and $23.5 million to the Center for Biologics Evaluation and Research.
In 2008, the FDA was budgeted around $2.27 billion, and the White House requested $2.4 billion for the agency in 2009.
In January, an FDA subcommittee released a report stating that the agency lacks the resources to keep up with advances in biomedical sciences, particularly changes and advances that have come from pharmacogenomics and genomics research and development.
The report from the agency’s Subcommittee on Science and Technology, said that the FDA “cannot fulfill its mission” in part “because its scientific workforce does not have sufficient capacity and capability.”